CHMP4C as a Novel Marker Regulates Prostate Cancer Progression through Cycle Pathways and Contributes to Immunotherapy
Researchers investigated the expression and clinical prognosis of charged multivesicular protein (CHMP) 4C and explored its potential regulatory mechanism in prostate cancer.
[Cell & Bioscience] Scientists demonstrated that CDK1 was correlated with prognosis and was highly expressed in pancreatic cancer tissue and gemcitabine-resistant cells
[Acta Biomaterialia] Researchers demonstrated that incorporating human pancreatic decellularized extracellular matrix within alginate microcapsules resulted in a significant increase in Glucose Stimulation Index and total insulin secreted by encapsulated human islets, compared to free islets and islets encapsulated in only alginate.
[Cancer Letters] In vivo and in vitro experiments revealed that FABP4 induced macrophage-related inflammation to promote pancreatic cancer cell migration, invasion, and metastasis under obese condition.